Your browser doesn't support javascript.
loading
Nephrotic-range proteinuria on interferon-ß treatment: immune-induced glomerulonephritis or other pathway?
Yuste, C; Rapalai, M; Pritchard, B A; Jones, T J; Tucker, B; Ramakrishna, S B.
  • Yuste C; Shrewsbury and Telford NHS Trust , Shorpshire, UK.
  • Rapalai M; Shrewsbury and Telford NHS Trust , Shorpshire, UK.
  • Pritchard BA; Shrewsbury and Telford NHS Trust , Shorpshire, UK.
  • Jones TJ; Shrewsbury and Telford NHS Trust , Shorpshire, UK.
  • Tucker B; King's College Hospital , London, UK.
  • Ramakrishna SB; Shrewsbury and Telford NHS Trust , Shorpshire, UK.
Clin Kidney J ; 7(2): 190-3, 2014 Apr.
Article en En | MEDLINE | ID: mdl-25852870
We present a case report of a 37-year-old woman with multiple sclerosis (MS) who developed nephrotic-range proteinuria secondary to membrano proliferative glomerulonephritis (MPGN)-like disease with mesangial C3 deposition without evidence of immune-complex deposition in the context of long-term interferon-ß (IFN-ß) therapy. The complete remission of proteinuria following cessation of IFN-ß, strongly suggests causality. To our knowledge, this is the second case report of MPGN associated with IFN-ß use. This being the case, the negative immune screen, normal inflammatory markers and the absence of immune complex deposits would imply a different pathway to that previously suggested.
Palabras clave